Urinary Incontinence After Radical Prostatectomy

Sponsor
Regional Hospital West Jutland (Other)
Overall Status
Recruiting
CT.gov ID
NCT05625048
Collaborator
(none)
66
1
3
35.6
1.9

Study Details

Study Description

Brief Summary

The aims of this project are; 1) To examine the efficacy of ultrasound-guided pelvic floor muscle training compared to standard care on urinary incontinence in patients undergoing robot assisted radical prostatectomy and 2) To compare physical function, incontinence, and QoL in two groups of patients with low or high function of the pelvic floor muscles respectively before the surgery.

This study consists of two parts. The first part is a randomized controlled trial where 44 patients with weak pelvic floor muscle function are randomized to either treatment as usual (control group 1) or ultrasound-guided pelvic floor muscle training (Intervention group). In the second part the patients in control group 1 will be compared with 22 patients with normal/strong pelvic floor muscle function (control group 2).

Patients not able to perform the pelvic floor muscle test consisting of 8 repetitions of 4-seconds pelvic floor muscle contraction and 1 repetition of 15-seconds pelvic floor muscle contraction will be randomized to either intervention group or control group 1. Patients able to perform the pelvic floor muscle test will be included in control group 2.

Condition or Disease Intervention/Treatment Phase
  • Other: Transperinal ultrasound guided instruction in pelvic floor muscle training
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
66 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double (Investigator, Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Urinary Incontinence After Radical Prostatectomy
Actual Study Start Date :
Oct 12, 2022
Anticipated Primary Completion Date :
Oct 1, 2024
Anticipated Study Completion Date :
Oct 1, 2025

Arms and Interventions

Arm Intervention/Treatment
Experimental: Intervention group

The intervention group receives same treatment as the control groups and in addition transperinal ultrasound guided instruction in pelvic floor muscle training at 2nd and 3rd session.

Other: Transperinal ultrasound guided instruction in pelvic floor muscle training
The physiotherapists uses transperinal ultrasound as a biofeedback or pedagogical tool to improve the muscle contractions and visualize the muscle work.

No Intervention: Control group 1

The patients recieve standard care including three physiotherapist sessions; within one week preoperatively, one week postoperatively at catheter removal, and six weeks postoperatively

No Intervention: Control group 2

The patients recieve standard care including three physiotherapist sessions; within one week preoperatively, one week postoperatively at catheter removal, and six weeks postoperatively

Outcome Measures

Primary Outcome Measures

  1. 24-hour pad weigh test [12 month after the operation]

    The patients have to weigh their pads before use and retain them in sealed plastic bags for repeated weight assessment when the 24-hour period has ended. The total increase in weight (gram) of all the pads will be recorded

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
Male
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Men aged 18 and above

  • Diagnosis of prostatic adenocarcinoma and referred to robot assisted radical prostatectomy

  • No comorbidity that prevents pelvic floor training or effects the function of the pelvic floor

  • Adequacy in written and spoken Danish Performance status 0-1

  • Able to understand the study procedures and willing to provide written informed consent

Exclusion Criteria:
  • Major surgery within the last month that may affect pelvic floor function.

  • Urinary incontinence prior to surgery

Contacts and Locations

Locations

Site City State Country Postal Code
1 Regional Hospital Goedstrup Herning Denmark 7400

Sponsors and Collaborators

  • Regional Hospital West Jutland

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Sara Birch, Principal investigator, Regional Hospital West Jutland
ClinicalTrials.gov Identifier:
NCT05625048
Other Study ID Numbers:
  • 1-10-72-356-21
First Posted:
Nov 22, 2022
Last Update Posted:
Nov 22, 2022
Last Verified:
Nov 1, 2022
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Nov 22, 2022